(Q40563987)

21 September 2017

1 reference

title

Antibody-targeted drugs for the therapy of cancer (English)

1 reference

21 September 2017

Pietersz GA

1

1 reference

PubMed ID

7812691

21 September 2017

Krauer K

series ordinal

2

1 reference

21 September 2017

1 January 1994

1 reference

Journal of Drug Targeting

21 September 2017

1 reference

21 September 2017

2

1 reference

21 September 2017

183-215

1 reference

21 September 2017

3

1 reference

Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.

21 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Increased intratumor concentration of fluorescein-isothiocyanate-labeled neocarzinostatin in rats under angiotensin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

High-dose methotrexate: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma – implications for radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The mechanism of hepatic uptake of a radiolabelled monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Abnormal response of tumor vasculature to vasoactive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Therapeutic index: a vital component in selection of anticancer agents for clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Cytotoxicity of antibody-phospholipase C conjugates on cultured Friend leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Effects of tumor necrosis factor, alone or in combination with topoisomerase-II-targeted drugs, on human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Discussion paper: amethopterin linked covalently to water-soluble macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Trends in cancer mortality in 15 industrialized countries, 1969-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

High dose methotrexate therapy: Insecure rationale?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Radioimmunology. Imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Substance P increases rat aortic albumin permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Is screening for colorectal cancer worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Antitumor activity of recombinant human interleukin-1 against heterotransplanted human non-Hodgkin lymphomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Antiproliferative effect of interleukin 1 (IL-1) on tumor cells: G0-G1 arrest of a human melanoma cell line by IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Transfectomas provide novel chimeric antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Neuropeptides and inflammation: the role of substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Antibody conjugates for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Opening of the blood-brain barrier by acute hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The general immunopharmacology of levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Tumour necrosis factor: a cytokine with multiple biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The mode of action of methotrexate-monoclonal antibody conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Vascular damage and delayed cell death in tumours after hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Response of human tumor blood flow to local hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The pharmacology of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

The effects of hyperthermia on tumor carcinoembryonic antigen expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Human combinatorial antibody libraries to hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869408996804

10.3109/10611869408996804

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7812691